Ig Mg Antibodies
Lab Reagents
Human IgG antibody Laboratories manufactures the ig mg antibodies reagents distributed by Genprice. The Ig Mg Antibodies reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm antibody. Other Ig products are available in stock. Specificity: Ig Category: Mg Group: Antibodies
MG-132 |
|||
HY-13259 | MedChemExpress | 10mM/1mL | EUR 113 |
MG 1 |
|||
HY-U00110 | MedChemExpress | 5mg | EUR 601 |
MG-132 |
|||
20-abx076663 | Abbexa |
|
|
|
MG-132 |
|||
A2585-10 | ApexBio | 10 mg | EUR 108 |
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS. |
MG-132 |
|||
A2585-100 | ApexBio | 100 mg | EUR 421 |
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS. |
MG-132 |
|||
A2585-25 | ApexBio | 25 mg | EUR 189 |
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS. |
MG-132 |
|||
A2585-50 | ApexBio | 50 mg | EUR 305 |
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS. |
MG-132 |
|||
A2585-500 | ApexBio | 500 mg | EUR 1186 |
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS. |
MG-132 |
|||
A2585-S | ApexBio | Evaluation Sample | EUR 81 |
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS. |
MG-115 |
|||
A2612-100 | ApexBio | 100 mg | EUR 862 |
Description: MG-115 (Z-Leu-Leu-Nva-H) is a potent, reversible peptide aldehyde inhibitor of proteasome chymotrypsin-like and caspase-like activities. It induces p53 dependent apoptosis. Blockade of proteasomal degradation by MG115 can activate autophagy. |
MG-115 |
|||
A2612-25 | ApexBio | 25 mg | EUR 282 |
Description: MG-115 (Z-Leu-Leu-Nva-H) is a potent, reversible peptide aldehyde inhibitor of proteasome chymotrypsin-like and caspase-like activities. It induces p53 dependent apoptosis. Blockade of proteasomal degradation by MG115 can activate autophagy. |
MG-115 |
|||
A2612-5 | ApexBio | 5 mg | EUR 131 |
Description: MG-115 (Z-Leu-Leu-Nva-H) is a potent, reversible peptide aldehyde inhibitor of proteasome chymotrypsin-like and caspase-like activities. It induces p53 dependent apoptosis. Blockade of proteasomal degradation by MG115 can activate autophagy. |
MG-115 |
|||
A2612-S | ApexBio | Evaluation Sample | EUR 81 |
Description: MG-115 (Z-Leu-Leu-Nva-H) is a potent, reversible peptide aldehyde inhibitor of proteasome chymotrypsin-like and caspase-like activities. It induces p53 dependent apoptosis. Blockade of proteasomal degradation by MG115 can activate autophagy. |
MG-262 |
|||
A8179-1 | ApexBio | 1 mg | EUR 282 |
Description: MG-262 (also known as Z-Leu-Leu-Leu-B(OH)2), a boronic peptide acid, is a potent proteasome inhibitor that selectively and reversibly inhibits the chymotryptic activity of the proteasome. |
MG-262 |
|||
A8179-5 | ApexBio | 5 mg | EUR 862 |
Description: MG-262 (also known as Z-Leu-Leu-Leu-B(OH)2), a boronic peptide acid, is a potent proteasome inhibitor that selectively and reversibly inhibits the chymotryptic activity of the proteasome. |
MG-132 |
|||
1703-25 | Biovision | EUR 501 |
MG-132 |
|||
1703-5 | Biovision | EUR 175 |